Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity

Objective: To measure the serum level of IL4, IL10 and IFN-gamma of Atopic patients before and after treatment with tacrolimus ointment or topical steroid by using enzyme linked immunosorbant assay (ELISA) to evaluate the disease activity. Methods: IL4, IL10 and IFN-gamma concentrations in the s...

Full description

Bibliographic Details
Main Authors: Nidhal Abdul-Muhaimen, Ahmad Hachem Muhana
Format: Article
Language:English
Published: College of medicine/ University of Diyala 2019-11-01
Series:Diyala Journal of Medicine
Subjects:
Online Access:http://djm.uodiyala.edu.iq/index.php/djm/article/view/378
_version_ 1797454756898144256
author Nidhal Abdul-Muhaimen
Ahmad Hachem Muhana
author_facet Nidhal Abdul-Muhaimen
Ahmad Hachem Muhana
author_sort Nidhal Abdul-Muhaimen
collection DOAJ
description Objective: To measure the serum level of IL4, IL10 and IFN-gamma of Atopic patients before and after treatment with tacrolimus ointment or topical steroid by using enzyme linked immunosorbant assay (ELISA) to evaluate the disease activity. Methods: IL4, IL10 and IFN-gamma concentrations in the serum were measured by enzyme-linked immunosorbent assay in fifty atopic dermatitis patients were giving two types of treatment and 43/50 were re-analyzed after one month of treatment with tacrolimus or topical and systemic steroids. The severity of atopic dermatitis was graded on the criteria of Hanifin and Rajika. The disease activity was assessed by each patient on a visual analogue scale (VAS). Results: Higher serum IFN-γ, IL-10 and IL-4 concentrations were found in AD patients sera at the time of diagnosis and correlated with disease activity before and after treatment. Serum IFN-γ, IL-10 and IL-4 concentrations also correlated with VAS scores for itching, skin condition; overall skin symptoms and total VAS score. Serum IFN-γ concentration could be a good indicator to define the degree of the general activity in chronic AD patients, also IFN-γ can play a role in the immuno-pathogenesis of AD, and furthermore  may be used in the diagnosis and follow up of the disease in addition to other parameters. Conclusion: The sera of patients group revealed a statistically significant increase in the concentration of IFN-gamma, IL-4 and   IL-10 before treatment when compared with that of the same patients after treatment with topical tacrolimus-steroid and also there were no statistically significant differences between two treatments.
first_indexed 2024-03-09T15:42:41Z
format Article
id doaj.art-42448b943f054c7c95d415311ffa3ca6
institution Directory Open Access Journal
issn 2219-9764
2617-8982
language English
last_indexed 2024-03-09T15:42:41Z
publishDate 2019-11-01
publisher College of medicine/ University of Diyala
record_format Article
series Diyala Journal of Medicine
spelling doaj.art-42448b943f054c7c95d415311ffa3ca62023-11-24T23:23:47ZengCollege of medicine/ University of DiyalaDiyala Journal of Medicine2219-97642617-89822019-11-0152Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease ActivityNidhal Abdul-Muhaimen Ahmad Hachem Muhana Objective: To measure the serum level of IL4, IL10 and IFN-gamma of Atopic patients before and after treatment with tacrolimus ointment or topical steroid by using enzyme linked immunosorbant assay (ELISA) to evaluate the disease activity. Methods: IL4, IL10 and IFN-gamma concentrations in the serum were measured by enzyme-linked immunosorbent assay in fifty atopic dermatitis patients were giving two types of treatment and 43/50 were re-analyzed after one month of treatment with tacrolimus or topical and systemic steroids. The severity of atopic dermatitis was graded on the criteria of Hanifin and Rajika. The disease activity was assessed by each patient on a visual analogue scale (VAS). Results: Higher serum IFN-γ, IL-10 and IL-4 concentrations were found in AD patients sera at the time of diagnosis and correlated with disease activity before and after treatment. Serum IFN-γ, IL-10 and IL-4 concentrations also correlated with VAS scores for itching, skin condition; overall skin symptoms and total VAS score. Serum IFN-γ concentration could be a good indicator to define the degree of the general activity in chronic AD patients, also IFN-γ can play a role in the immuno-pathogenesis of AD, and furthermore  may be used in the diagnosis and follow up of the disease in addition to other parameters. Conclusion: The sera of patients group revealed a statistically significant increase in the concentration of IFN-gamma, IL-4 and   IL-10 before treatment when compared with that of the same patients after treatment with topical tacrolimus-steroid and also there were no statistically significant differences between two treatments. http://djm.uodiyala.edu.iq/index.php/djm/article/view/378Atopic dermatitis, interleukins, interferon gamma, tacrolimus
spellingShingle Nidhal Abdul-Muhaimen
Ahmad Hachem Muhana
Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
Diyala Journal of Medicine
Atopic dermatitis, interleukins, interferon gamma, tacrolimus
title Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
title_full Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
title_fullStr Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
title_full_unstemmed Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
title_short Serum Cytokine Levels in Patients with Chronic Atopic Dermatitis: a Useful Clinical Marker for Disease Activity
title_sort serum cytokine levels in patients with chronic atopic dermatitis a useful clinical marker for disease activity
topic Atopic dermatitis, interleukins, interferon gamma, tacrolimus
url http://djm.uodiyala.edu.iq/index.php/djm/article/view/378
work_keys_str_mv AT nidhalabdulmuhaimen serumcytokinelevelsinpatientswithchronicatopicdermatitisausefulclinicalmarkerfordiseaseactivity
AT ahmadhachemmuhana serumcytokinelevelsinpatientswithchronicatopicdermatitisausefulclinicalmarkerfordiseaseactivity